INVITED RESEARCH HIGHLIGHT
Year : 2015  |  Volume : 17  |  Issue : 5  |  Page : 769-770

Locally-advanced prostate cancer in the elderly: should we revisit our treatment paradigms?


Department of Urology, Istituto Clinico Humanitas, Rozzano, Italy

Correspondence Address:
Giovanni Lughezzani
Department of Urology, Istituto Clinico Humanitas, Rozzano
Italy
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/1008-682X.151394

Rights and Permissions

Prostate cancer (PCa) represents the most common malignancy in adult males with an estimated number of 280 000 newly diagnosed cases only in the United States in 2015. [1] Due to the introduction of PSA in clinical practice, the majority of the patients are currently diagnosed with organ-confined and sometimes indolent disease. However, a nonnegligible proportion of individuals are still diagnosed with locally-advanced tumors. In their recently published article, Bekelman et al. [2] focused on elderly patients with locally-advanced PCa in the attempt to determine the best treatment approach in this patient category, and concluded that, even in these individuals, androgen deprivation therapy (ADT) plus radiotherapy (RT) may confer a survival benefit relative to ADT alone. The importance of the current article resides in the fact that it focuses on a patient population that has not been, or has been only scarcely, included in previous studies on the same topic.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1415    
    Printed34    
    Emailed0    
    PDF Downloaded179    
    Comments [Add]    

Recommend this journal